SCHEMBL14083322

SCHEMBL14083322

COCCNc1cc(-c2ncccc2Cl)ccc1C(=O)Nc1cccc(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.48
▸ MAPT P10636 4/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ LMNA P02545 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ HTT P42858 2/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.45
▸ CSF1R P07333 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ TNIK Q9UKE5 1/20 0.44
▸ HSP90AA1 P07900 1/20 0.44
▸ HSP90AB1 P08238 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083321 0.90 RXFP1 (0.46) GRM4ALDH1A1MAPTKDM4ELMNA
SCHEMBL14083189 0.88 GRM4 (0.54) GRM4ALDH1A1MAPTKDM4ELMNA
SCHEMBL14083155 0.88 MAPT (0.50) GRM4ALDH1A1MAPTKDM4ELMNA
SCHEMBL14083326 0.88 GRM4 (0.53) GRM4ALDH1A1MAPTKDM4ELMNA
SCHEMBL14083340 0.87 RXFP1 (0.42) GRM4ALDH1A1KDM4ERXFP1HSP90AA1
SCHEMBL14083325 0.87 TRPV1 (0.48) GRM4ALDH1A1KDM4EMEN1KMT2A
SCHEMBL14083341 0.87 RXFP1 (0.64) ALDH1A1MAPTLMNANPSR1MEN1
SCHEMBL14083339 0.87 SMN1; SMN2 (0.46) ALDH1A1MAPTKDM4ELMNANPSR1
SCHEMBL14083333 0.87 RXFP1 (0.49) MAPTRXFP1
SCHEMBL14083338 0.86 TRPV1 (0.43) GRM4ALDH1A1KDM4ERXFP1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 GRM4 362/4885ALDH1A1 1577/4885MAPT 2822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback